Glad I took treatment. (Dut, fin,min, microneedling)
    Progress Pictures 8/14/2025

    From the encyclopedia
    Dutasteride →

    Heavy duty finasteride that comes with higher risks

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💊 Dutasteride (oral) 0.5mg once daily 45 days
    💧 Minoxidil (topical) 10% twice daily 45 days
    💧 Finasteride (topical) 0.1% twice daily 45 days
    Microneedling (dermarolling) 1.5mm twice weekly 45 days
    💊 Multivitamin (oral) once daily 45 days
    💊 D3 K2 (oral)
    💊 Omega 3 fish oil (oral)
    the tone is 😀 positive with some growth results.

    Other terms

    The user is using a hair loss treatment involving dutasteride, minoxidil, finasteride, microneedling, and supplements like multivitamins, D3 K2, and Omega 3 fish oil. They are considering adding tretinoin and are open to suggestions while managing gut issues.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

      community Dut, Oral fin, Topical Fin+min, Topical min, Multivitamins, Microneedling, Keto, Prp

       9 upvotes 1 year ago
      The user is using a regimen of 1mg Dutasteride daily, topical finasteride and minoxidil, multivitamins, and supplements to address hair loss but hasn't seen improvement. Suggestions include sticking to one medication, considering oral minoxidil, and possibly a hair transplant, while noting that some treatments may not regrow hair.

      community 22 M current protocol: dut+microneedling+min

      in Progress Pictures  24 upvotes 1 year ago
      A 22-year-old is using a hair loss treatment protocol including dutasteride, microneedling, 10% minoxidil, 0.1% finasteride topical, a healthy diet, and a hair multivitamin. Users discuss the effectiveness of microneedling and the intensity of the treatment.

    Related Research

    6 / 6 results
      Safety Concerns When Using Novel Medications to Treat Alopecia

      research Safety concerns when using novel medications to treat alopecia

      23 citations , October 2018 in “Expert Opinion on Drug Safety”
      This review discusses the safety concerns associated with new treatments for non-scarring alopecias, highlighting that while these therapies such as JAK inhibitors and oral minoxidil show efficacy in hair regrowth, their safety profiles vary significantly, requiring careful consideration of benefits and risks.
      Minimally Invasive Non-Surgical Therapies for Androgenetic Alopecia: A Narrative Review of Clinical Evidence for Regenerative and Locally Acting Antiandrogen Treatments

      research Minimally Invasive Non-Surgical Therapies for Androgenetic Alopecia: A Narrative Review of Clinical Evidence for Regenerative and Locally Acting Antiandrogen Treatments

      March 2026 in “Preprints.org”
      This study reviewed evidence for six minimally invasive treatments for androgenetic alopecia, finding consistent support for platelet-rich plasma and topical finasteride, while other options like microneedling and intradermal dutasteride showed promise but need further and standardized research.
      Managing Patterned Hair Loss – A Hair Raising Task!

      research Managing patterned hair loss – a hair raising task!

      October 2021 in “Cosmoderma”
      This review summarizes existing knowledge on diffuse and patterned alopecia, emphasizing recent advancements in treatment beyond FDA-approved options, but it reports no new clinical findings.

      research Male androgenetic alopecia

      January 2025 in “Anais Brasileiros de Dermatologia”
      This review examines male androgenetic alopecia and reports no new clinical results, offering insights to aid dermatologists in making informed therapeutic decisions.
      Androgenetic Alopecia: An Update

      research Androgenetic alopecia: An update

      July 2023 in “JAAD International”
      This study describes androgenetic alopecia as a common non-scarring hair loss condition primarily influenced by genetic factors and androgen sensitivity, notably impacting psychosocial well-being, especially in females and younger males seeking treatment.
      Clinical Trials and Hair Loss

      research Clinical Trials and Hair Loss

      1 citations , July 2018 in “Elsevier eBooks”
      This review explores the current treatments for different types of alopecia, emphasizing the need for well-designed clinical trials and highlighting that most therapies are used off-label, as only androgenetic alopecia has FDA-approved drugs.